Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2022 Aug;40(8):2129-2134.
doi: 10.1007/s00345-022-04057-5. Epub 2022 Jun 9.

The intraureteral placement of the stent's distal end decreases stent-related urinary symptoms: a prospective randomized clinical trial

Kai-Yi Tzou  1   2 , Kuan-Chou Chen  1   2   3 , Chia-Chang Wu  1   2 , Su-Wei Hu  1 , Chen-Hsun Ho  4   5
Affiliations
Randomized Controlled Trial

The intraureteral placement of the stent's distal end decreases stent-related urinary symptoms: a prospective randomized clinical trial

Kai-Yi Tzou et al. World J Urol. 2022 Aug.

Abstract

Purpose: We compared intraureteral stent placement (CIU-SP) with conventional stent placement (C-SP) regarding the stent-related symptoms.

Methods: We randomized patients who underwent ureteroscopic lithotripsy into two groups. In CIU-SP group, a 16-cm or 18-cm stent was placed with its distal end above the ureterovesical junction. In C-SP group, a 22-cm or 24-cm stent was placed in a conventional method. Stent-related symptoms were assessed with the Ureteral Stent Symptom Questionnaire (USSQ) before the stent was removed, around 7 days after the operation. The primary outcome was the urinary symptoms; the secondary outcomes included postoperative pain and quality of life.

Results: We randomized 103 patients, of which 91 (45 in CIU-SP and 46 in C-SP) entered the final analysis. Regarding the primary endpoint, the CIU group had less urinary symptoms; the mean USSQ urinary symptom score was significantly lower in the CIU-SP versus C-SP group (25.5 ± 6.3 vs 31.7 ± 5.9, P < 0.001). The CIU-SP group also had more favorable profiles in the following outcomes: lower USSQ body pain score (15.5 ± 5.3 vs 20.1 ± 5.2, P < 0.001), lower overall pain score (3.2 ± 2.2 vs 5.7 ± 2.3, P < 0.001), less number of pain site (1.0 ± 0.9 vs 1.7 ± 0.9, P = 0.001, lower USSQ general health score (10.4 ± 3.7 versus 13.9 ± 3.4, P < 0.001), and lower USSQ work performance score (5.2 ± 3.3 versus 6.7 ± 2.8, P = 0.033). In either group, there was no complication of Clavien-Dindo Class 2 or greater.

Conclusion: The complete intraureteral placement significantly decreases stent-related urinary symptoms and pain. It is also associated with better postoperative general health condition and is less likely to limit physical activity and work ability.

Keywords: Pain; Quality of life; Stent; Ureter; Urinary symptoms.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

References

    1. Lingeman JE, Preminger GM, Goldfischer ER et al (2009) Assessing the impact of ureteral stent design on patient comfort. J Urol 181:2581–2587 - DOI
    1. Hiller SC, Daignault-Newton S, Pimentel H et al (2021) Ureteral Stent Placement following ureteroscopy increases emergency department visits in a statewide surgical collaborative. J Urol 205:1710–1717 - DOI
    1. Dunn MD, Portis AJ, Kahn SA et al (2000) Clinical effectiveness of new stent design: randomized single-blind comparison of tail and double-pigtail stents. J Endourol 14:195–202 - DOI
    1. Wu G, Sun F, Sun K et al (2021) Impact of differential ureteral stent diameters on clinical outcomes after ureteroscopy intracorporeal lithotripsy: a systematic review and meta-analysis. Int J Urol. https://doi.org/10.1111/iju.14631 - DOI - PubMed
    1. Damiano R, Autorino R, De Sio M et al (2005) Does the size of ureteral stent impact urinary symptoms and quality of life? A prospective randomized study. Eur Urol 48:673–678 - DOI

Publication types

LinkOut - more resources